Art. 30 Verdrag tussen het Koninkrijk der Nederlanden en het Europees Geneesmiddelenbureau betreffende de vestiging van het Europees Geneesmiddelenbureau — Entry into force and termination

1. The Agreement shall enter into force on the date of its signature by the Parties. 2. This Agreement shall cease to be in force by mutual consent of the Parties, or if the seat of the Agency is not confirmed in Amsterdam upon the conclusion of the on-going legislative process of amendments to Regulation (EC) No. 726/2004, or is eventually removed from the territory of the host State, or if the Agency is dissolved, except for such provisions as may be applicable in connection with the orderly termination of the operations of the Agency at its headquarters in the host State and the disposition of its property therein, as well as provisions granting immunity from legal process of every kind in respect of words spoken or written or all acts performed in an official capacity under this Agreement.

Rechtspraak bij dit artikel